Stockscreener 앱 받기
5.68
1.97%
0.11
시간 외 거래:
5.68
Zura Bio Ltd 주식(ZURA)의 최신 뉴스
Zura Bio updates corporate presentation; HS Phase 2 topline Q4 2026, SSc readout H1 2027, cash runway through 2028 - TradingView
ZURA (ZURA) insider Someit Sidhu plans 40,000-share sale after option exercise - Stock Titan
Zura Bio Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Zura Bio Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Guggenheim raises Zura Bio stock price target on new drug indication - Investing.com
Zura Bio Submits Q2 2026 SEC Report Highlighting Financial and Operational Status - Kalkine Media
Zura Bio Q2 Results: EPS Misses Estimate as Losses Widen 23.53% YoY - scanx.trade
Zura Bio Limited Reports Q2 2026 Financial Results and Updates Investor Presentation in 8-K Filing - Kalkine Media
Form 8K Zura Bio Limited For: 11 August By Investing.com - Investing.com Nigeria
Zura Bio Ltd 2Q 2026: Net loss $(26.3)M, EPS $(0.21) — 10-Q Summary - TradingView
Financial update and recent changes drive Zura Bio performance - Traders Union
Zura Bio Completes Enrollment in 247-Participant Hidradenitis Study - Stock Titan
Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - Yahoo Finance
Zura Bio Ltd expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Zura Bio Ltd (ZURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zura Bio (ZURA) Projected to Announce Earnings on Thursday - MarketBeat
Zura Bio Ltd (ZURA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zura Bio Ltd (ZURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zura Bio Ltd (ZURA) Cash Flow - TradingKey
Zura Bio Ltd (ZURA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Zura Bio Ltd (ZURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ZURA|Zura Bio Ltd|Price:5.230|Chg%:-0.060 - TradingKey
Zura Bio Ltd (ZURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ZURA|Zura Bio Ltd|Price:5.240|Chg%:-0.140 - TradingKey
TradingKey - TradingKey
Marlyn Teresa Mathew Net Worth (2026) - GuruFocus
William Blair Starts Zura Bio (ZURA) at Outperform - Yahoo Finance
ZURA Initiated Coverage by William Blair -- Rating Set to Outper - GuruFocus
What's Going on With Zura Bio Stock Wednesday?Zura Bio (NASDAQ:ZURA) - Benzinga
Zura Bio navigates growth path amid biotech volatility - Ad-hoc-news.de
William Blair initiates Zura Bio stock with outperform rating By Investing.com - Investing.com Nigeria
William Blair initiates Zura Bio stock with outperform rating - Investing.com
William Blair Initiates Zura Bio(ZURA.US) With Buy Rating - Moomoo
Zura Bio stock. Company profile and listing context. - Ad-hoc-news.de
Wedbush reiterates Outperform on Zura Bio, maintains $15 target - scanx.trade
Zura Bio’s Tibulizumab: First Dual BAFF & IL-17 Bispecific Antibody for Complex Autoimmune Diseases, Advancing in Phase 2 Trials – Minichart - Minichart
Jessica Chen - White & Case LLP
Zura Bio updates corporate presentation; tibulizumab Phase 2 toplines, $225.6M cash (Mar 31, 2026) - TradingView
Zura Bio (NASDAQ: ZURA) furnishes updated corporate presentation for investors - Stock Titan
Guggenheim Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $15 - Moomoo
We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely - simplywall.st
Zura Bio completes enrollment in tibulizumab trials By Investing.com - Investing.com South Africa
ZURA Financial Update: Cash Position and Operational Outlook - GuruFocus
Zura Bio completes Phase 2 trial enrollment for tibulizumab in hidradenitis suppurativa - Traders Union
Zura Bio clears enrollment targets in two Phase 2 studies, adds a third - Stock Titan
Zura Bio completes enrollment in TibuSHIELD Phase 2 HS trial - scanx.trade
Zura Bio (ZURA) VP details share, RSU and option holdings - Stock Titan
Zura Bio | 4: Statement of changes in beneficial ownership of securities-Director Jarrett Jennifer - Moomoo
Zura Bio (NASDAQ: ZURA) director receives grant of 51,000 share options - Stock Titan
Zura Bio (ZURA) director awarded 51,000 share options at $3.62 - Stock Titan
Zura Bio (ZURA) director receives grant of 51,000 stock options - Stock Titan
Zura Bio (ZURA) director Amit Munshi granted 51,000 share options at $3.62 - Stock Titan
Zura Bio (ZURA) director Daniel Becker receives 51,000 share options at $3.62 - Stock Titan
Director at Zura Bio (NASDAQ: ZURA) granted 51,000 stock options - Stock Titan
Zura Bio (ZURA) director receives 51,000 share options at $3.62 strike price - Stock Titan
Zura Bio StockSaturday look at the business model and pipeline - AD HOC NEWS
Zura Bio (NASDAQ: ZURA) investors approve board slate, auditor and 2023 equity plan changes - Stock Titan
Zura Bio Ltd (ZURA) Institutional Confidence - TradingKey
1.80%
1.77%
자본화:
|
볼륨(24시간):